Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARQT | AZN | AMGN | GILD | BMY |
| Company | Arcutis Biotherapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 24.26 | 202.64 | 347.46 | 140.12 | 58.70 |
| High | 25.03 | 206.50 | 359.45 | 142.97 | 59.69 |
| Low | 24.03 | 201.97 | 346.42 | 139.96 | 58.54 |
| Latest | 24.57 | 204.99 | 355.60 | 142.09 | 59.47 |
| Change | -0.04 | +0.72 | +5.79 | +0.55 | +0.27 |
| % Change | -0.16% | +0.35% | +1.66% | +0.39% | +0.46% |
| Volume | 837,900 | 1,239,200 | 2,940,900 | 4,167,400 | 6,572,300 |
| 20-Day Average Volume | 1,344,830 | 1,894,615 | 2,729,830 | 6,034,525 | 13,469,005 |
| Previous Close | 24.61 | 204.27 | 349.81 | 141.54 | 59.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.88 | 193.18 | 352.73 | 140.13 | 59.05 |
| 20-Day Raw Stochastic | 88.24% | 92.85% | 51.43% | 57.22% | 52.29% |
| 20-Day Relative Strength | 51.99 | 60.42 | 49.69 | 51.65 | 51.40 |
| Weighted Alpha | +70.22 | +54.08 | +25.66 | +37.30 | +24.13 |
| Today's Opinion | 8% Buy | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Previous Opinion | 8% Buy | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 8% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.95% since 04/01/26 | +2.12% since 04/01/26 | +0.66% since 04/01/26 | +1.28% since 04/01/26 | -3.66% since 04/01/26 |
| Low | 22.97 on 04/07/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 25.03 on 04/09/26 | 206.73 on 04/08/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.58 on 04/02/26 |
| 1-Month | |||||
| %Chg | -1.01% since 03/09/26 | +5.15% since 03/09/26 | -5.67% since 03/09/26 | -3.10% since 03/09/26 | -1.91% since 03/09/26 |
| Low | 21.12 on 03/30/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 25.53 on 03/10/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -12.93% since 01/09/26 | +8.29% since 01/09/26 | +9.05% since 01/09/26 | +17.33% since 01/09/26 | +6.46% since 01/09/26 |
| Low | 21.12 on 03/30/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 28.80 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +18.64% since 10/09/25 | +20.53% since 10/09/25 | +20.37% since 10/09/25 | +21.71% since 10/09/25 | +33.10% since 10/09/25 |
| Low | 19.60 on 10/27/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 31.77 on 12/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,052,452 | 316,803,968 | 188,571,376 | 175,682,560 | 120,870,712 |
| Shares Outstanding, K | 124,033 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 376,070,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -16,140,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 129,500,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 17,400,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.76 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 02/25/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.92 | 15.56 | 17.03 | 9.38 |